Literature DB >> 21046529

[Treatment decisions in advanced cancer. An empirical-ethical study on physicians' criteria and the process of decision making].

J Schildmann1, J Vollmann.   

Abstract

BACKGROUND AND RESEARCH QUESTION: Physicians' decisions regarding the indication of medical treatment are central to the application or limitation of medical measures in advanced cancer. This qualitative study explores criteria and procedural aspects of treatment decisions with patients with cancer near the end of life from the perspective of oncologists. RESEARCH PARTICIPANTS AND METHODS: In this qualitative interview study physicians working in the field of oncology were asked about their decisional criteria and procedural aspects of treatment decision making in cases of patients with advanced cancer. All interviews were audiotaped and transcribed. Qualitative data analysis was conducted in accordance with principles of "Grounded Theory".
RESULTS: 17 research interviews had been analysed. Next to medical criteria the life-circumstances of the patients with respect to age and social situation as well as the perceived quality of the physician-patient-relationship were named as foundation for decisions about the application or limitation of medical treatment at the end of life. In addition situational factors such as time pressure or the available technical equipment were cited as relevant factors for the decisions. "Silent acquiescence" as the predominant decision making model which has been reconstructed on the basis of the narratives means that decisions about the limitation of medical treatment are not communicated explicitly within the physician-patient-relationship. This approach was justified by the interviewees in light of the long standing relationship between physicians and patients.
CONCLUSIONS: The decisional criteria and procedural aspects of decision making in patients with advanced cancer which have been elicited in this qualitative study inform the current scientific and societal debate on ethically relevant aspects of end-of-life decision making in medicine. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2010        PMID: 21046529     DOI: 10.1055/s-0030-1267505

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  6 in total

1.  "Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.

Authors:  Jan Schildmann; Jacinta Tan; Sabine Salloch; Jochen Vollmann
Journal:  Oncologist       Date:  2013-01-03

2.  Empirical research in medical ethics: how conceptual accounts on normative-empirical collaboration may improve research practice.

Authors:  Sabine Salloch; Jan Schildmann; Jochen Vollmann
Journal:  BMC Med Ethics       Date:  2012-04-13       Impact factor: 2.652

3.  Limiting treatment and shortening of life: data from a cross-sectional survey in Germany on frequencies, determinants and patients' involvement.

Authors:  Birte Malena Dahmen; Jochen Vollmann; Stephan Nadolny; Jan Schildmann
Journal:  BMC Palliat Care       Date:  2017-01-17       Impact factor: 3.234

4.  Equal cancer treatment regardless of education level and family support? A qualitative study of oncologists' decision-making.

Authors:  Nina Cavalli-Björkman; Bengt Glimelius; Peter Strang
Journal:  BMJ Open       Date:  2012-08-24       Impact factor: 2.692

5.  Chemotherapy near the end of life: a retrospective single-centre analysis of patients' charts.

Authors:  Hanny Adam; Sonja Hug; Georg Bosshard
Journal:  BMC Palliat Care       Date:  2014-05-22       Impact factor: 3.234

6.  Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies decision-making.

Authors:  Yvan Beaussant; Florence Mathieu-Nicot; Lionel Pazart; Christophe Tournigand; Serge Daneault; Elodie Cretin; Aurélie Godard-Marceau; Aline Chassagne; Hélène Trimaille; Carole Bouleuc; Patrice Cuynet; Eric Deconinck; Régis Aubry
Journal:  BMC Palliat Care       Date:  2015-11-16       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.